Daniel Grosslight
Stock Analyst at Citigroup
(1.35)
# 3,294
Out of 4,784 analysts
98
Total ratings
38.6%
Success rate
-12.08%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Reiterates: Sell | $27 | $29.14 | -7.34% | 9 | Mar 6, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $120 → $129 | $136.44 | -5.45% | 5 | Jan 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $9.60 | +87.50% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.50 | +38.89% | 7 | Jan 10, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $11 → $10 | $4.55 | +119.78% | 8 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $668.06 | +1.34% | 7 | Jan 10, 2025 | |
| PHR Phreesia | Maintains: Buy | $31 → $35 | $26.00 | +34.62% | 6 | Jan 10, 2025 | |
| AGL agilon health | Upgrades: Neutral | $1.75 → $2.25 | $4.49 | -49.89% | 4 | Jan 10, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $21 → $19 | $8.58 | +115.62% | 5 | Nov 5, 2024 | |
| PRVA Privia Health Group | Initiates: Buy | $25 | $22.59 | +10.67% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $9.4 | $0.61 | +1,450.39% | 10 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $8.09 | +134.86% | 10 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $6.58 | +51.98% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $9.35 | -14.44% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $3.40 | -63.24% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.63 | +33.08% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.64 | +22.18% | 1 | Dec 11, 2019 |
Hims & Hers Health
Mar 6, 2025
Reiterates: Sell
Price Target: $27
Current: $29.14
Upside: -7.34%
Cardinal Health
Jan 10, 2025
Maintains: Neutral
Price Target: $120 → $129
Current: $136.44
Upside: -5.45%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $9.60
Upside: +87.50%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.50
Upside: +38.89%
Health Catalyst
Jan 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $4.55
Upside: +119.78%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $668.06
Upside: +1.34%
Phreesia
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $26.00
Upside: +34.62%
agilon health
Jan 10, 2025
Upgrades: Neutral
Price Target: $1.75 → $2.25
Current: $4.49
Upside: -49.89%
Owens & Minor
Nov 5, 2024
Maintains: Buy
Price Target: $21 → $19
Current: $8.58
Upside: +115.62%
Privia Health Group
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $22.59
Upside: +10.67%
Apr 16, 2024
Maintains: Neutral
Price Target: $17 → $9.4
Current: $0.61
Upside: +1,450.39%
Feb 21, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $8.09
Upside: +134.86%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $6.58
Upside: +51.98%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $9.35
Upside: -14.44%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $3.40
Upside: -63.24%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.63
Upside: +33.08%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $10.64
Upside: +22.18%